Danish Tech Firm Secures Funding to Transform Psychiatric Care

2026-08-22 digital

Amsterdam, Saturday 22 August 2026
Copenhagen-based Aisel Health has raised €1.7 million to launch its psychiatric data platform in the UK, aiming to reduce administrative burdens for clinicians.

A Synergistic Coalition of European Backers

The pre-seed funding round, which closed on 19 August 2026 [4][6] and was announced to the public on 21 August 2026 [2][5], represents a significant milestone for the Copenhagen-headquartered healthtech startup [3][7]. Led by Munich-based Caesar Ventures [1][2], the €1.7 million investment round also secured participation from Nordic Web Ventures, LifeX Ventures, and Angel Invest [1][7]. Crucially, existing early-stage backers, including Amsterdam-based Rockstart and Denmark’s state investment fund, EIFO, doubled down on their commitment to the company [1][2][4][7]. This capital injection is designed to support engineering and clinical hiring while laying the financial groundwork for rapid international market penetration [1][5][7].

Beyond the AI Scribe: Redefining Psychiatric Workflows

Founded in 2024 by Augusta Klingsten Peytz and Christian Houen [5], Aisel Health is steering away from the saturated market of generic AI transcription and scribing tools [1][7]. While basic AI scribes have gained popularity for writing notes faster to ease immediate clinician burnout, they fail to solve the systemic issue of information retrieval [1][2][5]. Aisel’s core philosophy is that making notes cheaper to produce simply makes fragmented clinical data harder to locate when a clinician actually needs it [1][2][5]. To address this, the company is building a comprehensive ‘operating system for psychiatry’ that aggregates and interprets complex patient histories [1][5][7].

Targeting the United Kingdom’s Private Healthcare Sector

With the €1.7 million injection secured, Aisel Health is actively expanding its clinical and technical teams to facilitate immediate entry into the United Kingdom [1][5][7]. The startup is not entering the UK blind; it already serves private psychiatry clients in the country and is actively converting a commercial pipeline of private psychiatry providers [1][5][6][7]. This strategic positioning allows Aisel Health to prove its scalability in a highly demanding market ahead of a planned, larger seed funding round [1][2][5][6].

Sources & Ecosystem Partners

venture capital digital health